Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory

BACKGROUND: Psoriasis symptoms have a significant negative impact on health-related quality of life, impairing physical functioning and well-being. OBJECTIVE: To evaluate the impact of brodalumab, a human anti-interleukin-17R monoclonal antibody, on psoriasis symptom severity as measured by a novel...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Gordon, KB, Kimball, AB, Chau, D, Viswanathan, HN, Li, J, Revicki, DA, Kricorian, G, Ortmeier, BG
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Publishing Ltd 2014
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153951/
https://ncbi.nlm.nih.gov/pubmed/24079852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.12636
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы